Quality Framework
Our Quality Framework
Independent third-party reports for selected lots, attributed to the issuing lab. The reports we publish are added as each cycle completes — see the report archive on /coa. For research purposes only.
+33 product lines covered by supplier spec
Class-level specifications are shown where one is on record. Independent reports cover selected tested lots; the issuing lab and available results are shown for each report.
What the published reports cover
Published reports cover the results stated by the issuing lab. Purity, content and additional panels are distinct; check the underlying report for its methods and scope.
Class-level specifications set the product-class standard (for example purity, identity or content) where one is on record. Selected lots have independent reports. The records linked from /coa identify the issuing lab.
What we don't do: CertaPeptides does not run HPLC, MS, LAL, or bioburden testing in-house. We don't publish per-vial measurement records. Published independent reports support the analytical results stated for their tested lots; supplier specifications are class-level standards.
Published Records
53 independent report records + 33 supplier batch specifications. Expand a row to view its recorded details.
86 records · Click a row to view its recorded details
Endotoxin
Endotoxin (LAL) results are shown as the figure the lab measured, with the lab and report number, and without a verdict. No badge or status on this page covers endotoxin.
- Retatrutide · CP-2608-RET30 · Endotoxin (LAL): <1 EU/vial · Janoshik report #233678
- Retatrutide · CP-2607-RET10 · Endotoxin (LAL): 1.022 EU/vial · Janoshik report #233669
- Retatrutide · CP-2608-RET5 · Endotoxin (LAL): <1 EU/vial · Janoshik report #233666
- Retatrutide · CP-2608-RET15 · Endotoxin (LAL): <1 EU/vial · Janoshik report #233672
- Retatrutide · CP-2608-RET20 · Endotoxin (LAL): 1.978 EU/vial · Janoshik report #233675
- Retatrutide · CP-2606-RET15 · Endotoxin (LAL): <1 EU/vial · Janoshik report #172229
- SS-31 · CP-2606-SS350 · Endotoxin (LAL): <1 EU/vial · Janoshik report #172220
| Batch # | Product | Result | Test Date | Status | |
|---|---|---|---|---|---|
| JV8GE17451DK | Pinealon | 98.094%10.58 mg (105.8% of label) | 2026-09-18 | PASS | |
| P29STAYN1SF6 | KPV | 98.786%11.93 mg (119.3% of label) | 2026-09-18 | PASS | |
| I7YDCQMYJIJ8 | VIP | 99.142%9.80 mg (98% of label) | 2026-09-18 | PASS | |
| KT9FA5IJ9TYA | SNAP-8 | 99.931%10.78 mg (107.8% of label) | 2026-09-18 | PASS | |
| 8XWT9FA4QZLY | Retatrutide | 99.639%32.96 mg (109.9% of label) | 2026-09-18 | PASS | |
| D84HFXBSQWJ7 | LL-37 | 99.379%4.74 mg (94.8% of label) | 2026-09-18 | PASS | |
| BFDKY9EV6Z9D | Kisspeptin-10 | 99.849%10.94 mg (109.4% of label) | 2026-09-18 | PASS | |
| YXBTMCEM4LZH | AHK-Cu | 99.120%94.49 mg (AHK 79.96 mg / Cu 14.53 mg) (94.5% of label) | 2026-09-18 | PASS | |
| TS91P24Q94T1 | DSIP | 99.307%5.67 mg (113.4% of label) | 2026-09-18 | PASS | |
| CXY67CGQ4RD1 | PT-141 | 99.976%9.73 mg (97.3% of label) | 2026-09-18 | PASS | |
| PALC8VXE3661 | MT-2 (Melanotan 2 Acetate) | 99.455%10.45 mg (104.5% of label) | 2026-09-18 | PASS | |
| 18H6ZBW9ZK12 | Selank | 99.163%36.70 mg (122.3% of label) | 2026-09-18 | PASS | |
| D513BBJEMRAK | Epitalon | 99.514%49.02 mg (98% of label) | 2026-09-18 | PASS | |
| 43XQNHEN8C7L | BPC-157 | 99.944%12.98 mg (129.8% of label) | 2026-09-18 | PASS | |
| QRHPKT4G6PPP | 5-amino-1mq | Content quantification (Janoshik)4.37 mg (87.4% of label) | 2026-09-17 | Content assay | |
| 3UCGA5FQMWI1 | Retatrutide | 99.427%9.61 mg (96.1% of label) | 2026-09-17 | PASS | |
| UH3TT3A5PUCF | Retatrutide | 99.268%5.17 mg (103.4% of label) | 2026-09-17 | PASS | |
| WS34N6J5494C | Retatrutide | 99.502%16.55 mg (110.3% of label) | 2026-09-17 | PASS | |
| 5QWFZ5HKMLZ5 | Retatrutide | 99.422%22.96 mg (114.8% of label) | 2026-09-17 | PASS | |
| F2HP9Y6BR9HK | KPV + GHK-Cu Blend | Content quantification (Janoshik)57.69 mg total (GHK-Cu 47.41 mg, of which GHK 41.70 mg and copper 5.71 mg; KPV 10.28 mg) (96.2% of label) | 2026-08-06 | Lot withdrawn | |
| GMT98LMSEV5K | Semax + Selank Blend | Content quantification (Janoshik)21.20 mg total (Selank 10.92 mg + Semax 10.28 mg) (106% of label) | 2026-08-06 | Content assay | |
| 1NSTIVUTWSXK | Cerebrolysin | Content quantification (Janoshik) | 2026-08-06 | Content assay | |
| TSIS765B8HAH | Retatrutide | 99.850%19.72 mg (98.6% of label) | 2026-08-06 | PASS | |
| 85CX8N5GSS5F | Retatrutide | 99.294%53.24 mg (106.5% of label) | 2026-08-06 | PASS | |
| GBYLRTD1N5UJ | Retatrutide | 99.901%33.91 mg (113% of label) | 2026-08-06 | PASS |
Verifying your batch
Every vial ships with a code printed on the label. Scan the QR or paste the code into /verify to see what CertaPeptides publishes for it and, for a withdrawn lot, the withdrawal and its reason. If the code finds nothing, email us that code.
Logged-in customers also see the order context — which order shipped this batch, when it shipped, and the carrier+AWB.
Research Articles
Our ≥98% commitment
If a Janoshik report on a published lot returns below 98% purity, contact us with your batch number — we investigate against the lot's published report and replace any unit that fails it, at no cost to you. Our published reports run higher — see the report archive on /coa.